Abstract:Background: While recent studies have separately explored mutational signatures and the tumor microenvironment (TME), there is limited research on the associations of both factors in a pan-cancer context. Materials and methods: We performed a pan-cancer analysis of over 8,000 tumor samples from The Cancer Genome Atlas (TCGA) project. Machine learning methods were employed to systematically explore the relationship between mutational signatures and TME and develop a risk score based on TME-associated mutational signatures to predict patient survival outcomes. We also constructed an interaction model to explore how mutational signatures and TME interact and influence cancer prognosis. Results: Our analysis revealed a varied association between mutational signatures and TME, with the Clock-like signature showing the most widespread influence. Risk scores based on mutational signatures mainly induced by Clock-like and AID/APOBEC activity exhibited strong pan-cancer survival stratification ability. We also propose a novel approach to predict transcriptome decomposed infiltration levels using genome-derived mutational signatures as an alternative approach for exploring TME cell types when transcriptome data are unavailable. Our comprehensive analysis revealed that certain mutational signatures and their interaction with immune cells significantly impact clinical outcomes in particular cancer types. For instance, T cell infiltration levels only served as a prognostic biomarker in melanoma patients with high ultraviolet radiation exposure, breast cancer patients with high homologous recombination deficiency signature, and lung adenocarcinoma patients with high tobacco-associated mutational signature. Conclusion: Our study comprehensively explains the complex interplay between mutational signatures and immune infiltration in cancer. The results highlight the importance of considering both mutational signatures and immune phenotypes in cancer research and their significant implications for developing personalized cancer treatments and more effective immunotherapy.

Histopathological Imaging–Environment Interactions in Cancer Modeling

Pathological Imaging-Assisted Cancer Gene-Environment Interaction Analysis

Histopathological imaging features- versus molecular measurements-based cancer prognosis modeling

Assessing the Effect of Data Integration on Predictive Ability of Cancer Survival Models

Molecular Imaging of the Tumor Microenvironment☆

Multidimensional molecular changes-environment interaction analysis for disease outcomes

Examination of Independent Prognostic Power of Gene Expressions and Histopathological Imaging Features in Cancer

Multidimensional Molecular Measurements-Environment Interaction Analysis for Disease Outcomes

Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis

Semiparametric integrative interaction analysis for non-small-cell lung cancer

Gene–environment interaction analysis under the Cox model

Modeling and understanding tumor biologic mechanisms.

Identification of Gene-Environment Interactions by Non-Parametric Kendall's Partial Correlation with Application to TCGA Ultrahigh-Dimensional Survival Genomic Data

A Bayesian mark interaction model for analysis of tumor pathology images

Abstract IA01: Modeling and understanding tumor biologic mechanisms

Integrative Analysis of Histopathological Images and Genomic Data in Colon Adenocarcinoma

An integrative analysis of cancer gene expression studies using Bayesian latent factor modeling

Histopathological Images and Multi-Omics Integration Predict Molecular Characteristics and Survival in Lung Adenocarcinoma

Modelling the Complex Smoking Exposure History in Assessment of Pan-Cancer Risk

Integrative Analysis Of Histopathological Images And Genomic Data Predicts Clear Cell Renal Cell Carcinoma Prognosis

Identifying Gene-Environment Interactions for Prognosis Using a Robust Approach